Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Adelstein

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cellsR S Adelstein, F S Collins, A Hajra, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1995
The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cellsA Hajra, P P Liu, Q Wang, et al.
Scientific Reports|April 12, 2016
Nonmuscle Myosin IIA Regulates Intestinal Epithelial Barrier in vivo and Plays a Protective Role During Experimental ColitisNayden G Naydenov, Alex Feygin, Dongdong Wang, et al.
Nature|May 26, 1994
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signallingY Nakamura, S M Russell, S A Mess, et al.
Cell|April 9, 1993
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humansM Noguchi, H Yi, H M Rosenblatt, et al.
Clinical and Experimental Immunology|August 12, 2009
Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiencyD A Fulcher, D T Avery, N L Fewings, et al.
Molecular Biology of the Cell|September 19, 2008
Rap1 activation in collagen phagocytosis is dependent on nonmuscle myosin II-APamela D Arora, Mary Anne Conti, Shoshana Ravid, et al.
Molecular Biology of the Cell|June 26, 2020
Nonmuscle myosin 2 regulates cortical stability during sprouting angiogenesisXuefei Ma, Yutaka Uchida, Tingyi Wei, et al.
Journal of Gastrointestinal Cancer|May 2, 2009
Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancerHeath B Mackley, Jonathan S Adelstein, Chandana A Reddy, et al.
Blood|March 30, 2007
The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathwayZhao Chen, Olaia Naveiras, Alessandra Balduini, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cellsR S Adelstein, F S Collins, A Hajra, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 1995
The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cellsA Hajra, P P Liu, Q Wang, et al.
Scientific Reports|April 12, 2016
Nonmuscle Myosin IIA Regulates Intestinal Epithelial Barrier in vivo and Plays a Protective Role During Experimental ColitisNayden G Naydenov, Alex Feygin, Dongdong Wang, et al.
Nature|May 26, 1994
Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signallingY Nakamura, S M Russell, S A Mess, et al.
Cell|April 9, 1993
Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humansM Noguchi, H Yi, H M Rosenblatt, et al.
Clinical and Experimental Immunology|August 12, 2009
Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiencyD A Fulcher, D T Avery, N L Fewings, et al.
Molecular Biology of the Cell|September 19, 2008
Rap1 activation in collagen phagocytosis is dependent on nonmuscle myosin II-APamela D Arora, Mary Anne Conti, Shoshana Ravid, et al.
Molecular Biology of the Cell|June 26, 2020
Nonmuscle myosin 2 regulates cortical stability during sprouting angiogenesisXuefei Ma, Yutaka Uchida, Tingyi Wei, et al.
Journal of Gastrointestinal Cancer|May 2, 2009
Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancerHeath B Mackley, Jonathan S Adelstein, Chandana A Reddy, et al.
Blood|March 30, 2007
The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathwayZhao Chen, Olaia Naveiras, Alessandra Balduini, et al.
Pageof 24